{"id":60644,"date":"2025-01-17T01:03:03","date_gmt":"2025-01-17T00:03:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/"},"modified":"2025-01-17T01:03:03","modified_gmt":"2025-01-17T00:03:03","slug":"mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/","title":{"rendered":"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024"},"content":{"rendered":"
\n

ATLANTA–(BUSINESS WIRE)–Mirion (NYSE: MIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results.<\/p>\n

<\/a>
<\/a><\/p>\n

\nParticipants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https:\/\/ir.mirion.com\/news-events<\/a>.<\/p>\n

\nA telephonic replay will be available shortly after the conclusion of the call and until <\/b>February 26, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with access code 13751221. An archived replay of the call will also be available on the Investors portion of the Mirion website at https:\/\/ir.mirion.com\/<\/a>.<\/p>\n

\nAbout Mirion<\/b><\/p>\n

\nMirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision \u2013 for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA \u2013 USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nEric Linn
\n
ir@mirion.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ATLANTA–(BUSINESS WIRE)–Mirion (NYSE: MIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results. Participants may … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60644","6":"format-standard","7":"category-industry"},"yoast_head":"\nMirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ATLANTA–(BUSINESS WIRE)–Mirion (NYSE: MIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results. Participants may ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-17T00:03:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250116115915\/en\/2355884\/22\/MirionCorp_Logo_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024\",\"datePublished\":\"2025-01-17T00:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/\"},\"wordCount\":273,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250116115915\\\/en\\\/2355884\\\/22\\\/MirionCorp_Logo_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/\",\"name\":\"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250116115915\\\/en\\\/2355884\\\/22\\\/MirionCorp_Logo_RGB.jpg\",\"datePublished\":\"2025-01-17T00:03:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250116115915\\\/en\\\/2355884\\\/22\\\/MirionCorp_Logo_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250116115915\\\/en\\\/2355884\\\/22\\\/MirionCorp_Logo_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/","og_locale":"en_US","og_type":"article","og_title":"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024 - Pharma Trend","og_description":"ATLANTA–(BUSINESS WIRE)–Mirion (NYSE: MIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results. Participants may ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/","og_site_name":"Pharma Trend","article_published_time":"2025-01-17T00:03:03+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250116115915\/en\/2355884\/22\/MirionCorp_Logo_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024","datePublished":"2025-01-17T00:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/"},"wordCount":273,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250116115915\/en\/2355884\/22\/MirionCorp_Logo_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/","url":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/","name":"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250116115915\/en\/2355884\/22\/MirionCorp_Logo_RGB.jpg","datePublished":"2025-01-17T00:03:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250116115915\/en\/2355884\/22\/MirionCorp_Logo_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250116115915\/en\/2355884\/22\/MirionCorp_Logo_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mirion-announces-earnings-release-and-conference-call-date-for-fourth-quarter-and-full-year-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60644"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60644\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}